106 related articles for article (PubMed ID: 31740393)
1. Drug-drug interaction between crizotinib and entecavir via renal secretory transporter OCT2.
Shu W; Ma L; Hu X; Zhang M; Chen W; Ma W; Huang J; Li J
Eur J Pharm Sci; 2020 Jan; 142():105153. PubMed ID: 31740393
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory Effect of Crizotinib on Creatinine Uptake by Renal Secretory Transporter OCT2.
Arakawa H; Omote S; Tamai I
J Pharm Sci; 2017 Sep; 106(9):2899-2903. PubMed ID: 28336299
[TBL] [Abstract][Full Text] [Related]
3. Fluorocholine Transport Mediated by the Organic Cation Transporter 2 (OCT2, SLC22A2): Implication for Imaging of Kidney Tumors.
Visentin M; Torozi A; Gai Z; Häusler S; Li C; Hiller C; Schraml PH; Moch H; Kullak-Ublick GA
Drug Metab Dispos; 2018 Aug; 46(8):1129-1136. PubMed ID: 29794161
[TBL] [Abstract][Full Text] [Related]
4. OAT1 and OAT3: targets of drug-drug interaction between entecavir and JBP485.
Xu Q; Wang C; Meng Q; Liu Q; Sun H; Peng J; Ma X; Kaku T; Liu K
Eur J Pharm Sci; 2013 Mar; 48(4-5):650-7. PubMed ID: 23313623
[TBL] [Abstract][Full Text] [Related]
5. Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats.
Shi R; Yang Y; Xu Z; Dai Y; Zheng M; Wang T; Li Y; Ma Y
Biopharm Drug Dispos; 2018 Jan; 39(1):47-58. PubMed ID: 29065218
[TBL] [Abstract][Full Text] [Related]
6. Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2).
Hörmann S; Gai Z; Kullak-Ublick GA; Visentin M
J Pharmacol Exp Ther; 2020 Jan; 372(1):46-53. PubMed ID: 31624079
[TBL] [Abstract][Full Text] [Related]
7. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
[TBL] [Abstract][Full Text] [Related]
8. Organic anion and cation transporters are possibly involved in renal excretion of entecavir in rats.
Yanxiao C; Ruijuan X; Jin Y; Lei C; Qian W; Xuefen Y; Hong T; Xueying Z; Davey AK; Jiping W
Life Sci; 2011 Jul; 89(1-2):1-6. PubMed ID: 21466809
[TBL] [Abstract][Full Text] [Related]
9. Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.
Omote S; Matsuoka N; Arakawa H; Nakanishi T; Tamai I
Sci Rep; 2018 Jun; 8(1):9237. PubMed ID: 29915248
[TBL] [Abstract][Full Text] [Related]
10. Effect of 7-ketocholesterol incorporation on substrate binding affinity and turnover rate of the organic cation transporter 2 (OCT2).
Xiu F; Console L; Indiveri C; Su S; Wang T; Visentin M
Biochem Pharmacol; 2024 Feb; 220():116017. PubMed ID: 38176620
[TBL] [Abstract][Full Text] [Related]
11. Incorporating renal excretion via the OCT2 transporter in physiologically based kinetic modelling to predict in vivo kinetics of mepiquat in rat.
Noorlander A; Wesseling S; Rietjens IMCM; van Ravenzwaay B
Toxicol Lett; 2021 Jun; 343():34-43. PubMed ID: 33639197
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the role of organic cation transporter 2 (OCT2) in the renal transport of guanfacine, a selective α2A-adrenoreceptor agonist.
Li X; Sun X; Chen J; Lu Y; Zhang Y; Wang C; Li J; Zhang Q; Zhao D; Chen X
Xenobiotica; 2015 Jan; 45(1):88-94. PubMed ID: 25115365
[TBL] [Abstract][Full Text] [Related]
13. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of
Parvez MM; Shin HJ; Jung JA; Shin JG
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
[No Abstract] [Full Text] [Related]
15. The oligopeptide transporter 2-mediated reabsorption of entecavir in rat kidney.
Xu Q; Wang C; Meng Q; Liu Q; Sun P; Sun H; Guo X; Liu K
Eur J Pharm Sci; 2014 Feb; 52():41-7. PubMed ID: 24184752
[TBL] [Abstract][Full Text] [Related]
16. Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine.
Meyer MJ; Seitz T; Brockmöller J; Tzvetkov MV
PLoS One; 2017; 12(12):e0189521. PubMed ID: 29236753
[TBL] [Abstract][Full Text] [Related]
17. Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.
Sandoval PJ; Morales M; Secomb TW; Wright SH
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F720-F734. PubMed ID: 31313952
[TBL] [Abstract][Full Text] [Related]
18. Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis.
Shen Q; Wang J; Yuan Z; Jiang Z; Shu T; Xu D; He J; Zhang L; Huang X
Int Immunopharmacol; 2019 Dec; 77():105959. PubMed ID: 31644961
[TBL] [Abstract][Full Text] [Related]
19. The conditional stimulation of rat organic cation transporter 2, but not its human ortholog, by mesoridazine: the possibility of the involvement of the high-affinity binding site of the transporter in the stimulation.
Hyung S; Pyeon W; Park JE; Song YK; Chung SJ
J Pharm Pharmacol; 2017 Nov; 69(11):1513-1523. PubMed ID: 28809437
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.
Zolk O; Solbach TF; König J; Fromm MF
Drug Metab Dispos; 2009 Jun; 37(6):1312-8. PubMed ID: 19251820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
